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Abstract
Over-activation of excitatory NMDA receptors and the resulting Ca2+ overload is the main
cause of neuronal toxicity during stroke. CaMKII becomes misregulated during such events.
Biochemical studies show either a dramatic loss of CaMKII activity or its persistent autono-
mous activation after stroke, with both of these processes being implicated in cell toxicity.
To complement the biochemical data, we monitored CaMKII activation in living hippocampal
neurons in slice cultures using high spatial/temporal resolution two-photon imaging of the
CaMKIIα FRET sensor, Camui. CaMKII activation state was estimated by measuring Camui
fluorescence lifetime. Short NMDA insult resulted in Camui activation followed by a redistri-
bution of its protein localization: an increase in spines, a decrease in dendritic shafts, and
concentration into numerous clusters in the cell soma. Camui activation was either persis-
tent (> 1–3 hours) or transient (~20 min) and, in general, correlated with its protein redistri-
bution. After longer NMDA insult, however, Camui redistribution persisted longer than its
activation, suggesting distinct regulation/phases of these processes. Mutational and phar-
macological analysis suggested that persistent Camui activation was due to prolonged
Ca2+ elevation, with little impact of autonomous states produced by T286 autophosphoryla-
tion and/or by C280/M281 oxidation. Cell injury was monitored using expressible mitochon-
drial marker mito-dsRed. Shortly after Camui activation and clustering, NMDA treatment
resulted in mitochondrial swelling, with persistence of the swelling temporarily linked to the
persistence of Camui activation. The results suggest that in living neurons excitotoxic insult
produces long-lasting Ca2+-dependent active state of CaMKII temporarily linked to cell inju-
ry. CaMKII function, however, is to be restricted due to strong clustering. The study provides
the first characterization of CaMKII activation dynamics in living neurons during excitotoxic
insults.
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Introduction
Most animal studies of stroke require that treatment be applied before or shortly after the
stroke event. This could be a reason why many clinical trials for stroke treatment based on
these studies have been negative [1]. Recently, it was shown that inhibitors of activated CaMKII
significantly decrease neuronal damage even if applied one hour after an experimental stroke
in vivo or 2–6 hours after an excitotoxic insult in neuronal cultures [2,3,4]. The results impli-
cate that an active state of CaMKII may last for many hours after stroke and play a significant
role in delayed brain toxicity. Understanding the mechanisms of this role is crucial for develop-
ing a new approach in “after-stroke” treatment.
Over-activation of the excitatory NMDA receptors and the resulting Ca2+ overload is the
main cause of neuronal toxicity during stroke [5]. CaMKII is one of the major Ca2+ sensors
in neurons and can operate as a molecular switch [6]. Under basal conditions, the regulatory
region of the kinase binds to and inhibits the catalytic region. When intracellular Ca2+ rises,
Ca2+/CaM binds to the regulatory region, leading to a separation of the regulatory and catalytic
regions rendering kinase activation. Autophosphorylation of the regulatory region at T286 pre-
vents regulatory and catalytic domains from rebinding and leads to persistent kinase activation
even after Ca2+ returns to the basal level. This Ca2+-independent (or autonomous) conforma-
tional state remains until T286 is dephosphorylated. Therefore, CaMKII can operate as a
switch, sustaining its active conformation after a transient activation. This memory-like prop-
erty has been shown to be critical for behavioral and synaptic memory [7,8,9] but has been also
implicated as both a cell damaging and pro-survival force in ischemic/ excitotoxic insult [4].
Despite considerable efforts, even the time course of CaMKII activation after ischemic/exci-
totoxic insult remains controversial. Currently, there are two major groups of results, which
are not easily reconcilable. During the first minute of ischemia, CaMKII undergoes brief in-
crease in Ca2+-dependent and Ca2+-independent activation [10] and autophosphorylation at
T286 [11,12]. Most studies of the first group described this initial phase of activation as very
short (1 min) [10,13]. In the following period, a loss of Ca2+-dependent [10,14,15,16,17,18,19],
Ca2+-independent [10,17,19] activity and T286 phosphorylation [19,20] was observed. Some
reduced level of persistent activity and T286 phosphorylation still remained during a prolonged
ischemia [10,17,21,22,23] and during the following reperfusion [19,20,22]. In contrast, the sec-
ond group of studies reported a fast (3 min) and prolonged (at least 30 min) increase in CaM-
KII phosphorylation of T286 in the total homogenate and membrane fractions (including
PSD/synaptosomal) during ischemia [11], which stayed elevated for at least 30–60 min or lon-
ger during the reperfusion [22,23,24]. Therefore, some evidence support persistent activation
while others support persistent inactivation of CaMKII after an excitotoxic event.
All studies, however, agreed that, very shortly after the start of ischemia, CaMKII translo-
cates from the cytosolic to the particulate fraction [10,16, 17,19,20,21,22,25] and, specifically,
to the postsynaptic density (PSD) fraction. Imaging studies showed, that in addition, to the
PSD, CaMKII gets sequestered into dense aggregates or clusters in cell somas [26,27,28,29,30].
It was suggested that the particulate fraction accumulation and clustering may serve as a pro-
tection mechanism to prevent cell from hyperphosphorylation by CaMKII [16,26]. However,
long-lasting inhibition of CaMKII due to aggregation could also be deleterious to cell function
and survival [3,14,31].
Based on these findings, two alternative hypotheses were put forward. One group proposed
that the loss of CaMKII activity was a critical factor in the ischemic cell damage; the other
group suggested that the over-activation of the kinase due to a persistent autonomous state in-
duced cell damage. Recent results added significant support to the second hypothesis: strong
evidence was presented that a persistence of CaMKII in autonomous (“active”) state was
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required to produce cell damage after an ischemic or excitotoxic insults. Specifically, it was
shown that inhibitors of active state (CN21 or AIP), but not an inhibitor of Ca2+/CaM-depen-
dent activation (KN93) of CaMKII significantly decreased cell death even if they were applied
hours after an ischemic or excitotoxic insult [2,3]. One possibility, which could reconcile the
apparent contradiction in results, is that the autonomous CaMKII constitutes only a fraction of
the total kinase in tissue, perhaps localized at a small cell population or in subcellular domains
such as synapses or intracellular organelles. These domains may contribute very little to bio-
chemical measurements of total CaMKII activity, yet still play a significant role in cell damage
after ischemia.
Therefore, to complement the biochemical data, we directly measured the changes in the ac-
tivation state of CaMKII in living hippocampal neurons in slice cultures using the CaMKII ac-
tivity sensor, green Camui (Camui) [32]. One advantage of this approach is that CaMKII
activation state can be differentially monitored in soma, dendrites, or dendritic spines at high
spatial and temporal resolution. The Camui sensor is composed of CaMKIIα tagged with dVe-
nus and GFP fluorophores on its N and C termini, respectively. Upon CaMKII activation, the
distance between the termini increases, leading to a decrease in the Forster resonance energy
transfer (FRET) between the fluorophores (see also [33,34,35,36]) and to an increase in GFP
lifetime [32]. Therefore, change in the fluorescent lifetime of the Camui GFP reveals transition
of CaMKII between its closed (inactive) and open (active) states [32]. Previously, experiments
in vitro and in living cultured cells clearly demonstrated an increase in Camui fluorescence
lifetime upon CaMKII activation by Ca2+/CaM or upon its transition into an autonomous
(Ca2+-independent) active state [32,33,34]. Following Lee at al., 2009, we will use the terms “ac-
tivation” and “increase in fluorescence lifetime” interchangeably in this text. Strictly speaking,
however, it is possible that, while in open “autonomous” or “active” conformational state, the
enzymatic activity of Camui is inhibited due to masking of catalytic sites by an inhibitor [34] or
other structural rearrangements, including CaMKII aggregation induced by self-association
[28,29,37].
To estimate the downstream consequences of an NMDA excitotoxic insult on neuronal
health, we monitored mitochondrial damage as a readout of cell injury associated with cell
death after ischemic/excitotoxic insults [38,39,40]. Our data indicate that in living cells an exci-
totoxic insult results in a long-lasting Ca2+-dependent activation of CaMKII, with a limited im-
pact of the autonomous kinase state. The duration of CaMKII activation was temporarily
linked to the duration of mitochondrial damage. Extensive CaMKII clustering, however, sug-
gests a dramatic loss of normal kinase function.
Materials and Methods
Slice culture preparation and DNA transfection
Hippocampal slice cultures were prepared from Long-Evans rats at P6–9 and were maintained
for 11–14 days as described earlier [41] before cDNA transfection. Transfection of cDNA into
CA1 pyramidal cells was performed by single-cell electroporation [8,42,43]. Two slightly differ-
ent variants of the wild-type (WT) Camui and its mutants were used. The differences were due
to different methods of the fluorophore subcloning. Specifically, variant 1 Camui had an addi-
tional 26 amino acid sequence (SGLRSRAQASNSAVDGTAGPGSTGSR) at the end of GFP.
Although both versions produced qualitatively similar results, the quantitative results for the
duration of persistent activation were slightly different, and the data for each type of Camui are
therefore presented separately. K42R and I205K mutants were prepared using variant 1 Camui
and T286A/CM280/281VV, or CM280/281VV mutants were prepared using variant 2 Camui.
For control experiments, Camui of the same variant as corresponding mutants were used.
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Control and mutant experiments were performed on the same or on a consecutive day using
slices from the same preparation. Camui reactivity and redistribution in response to glutamate
uncaging in spines were extensively characterized previously [32]. In that study, both Camui
variants produced similar results, and all data were pooled together. In some experiments to-
gether with Camui, we also coexpressed mito-dsRed cDNA (Clontech Lab., Inc.) to label mito-
chondria. The study was carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal Experiments of the Brandeis
University (PHS Animal Assurance #: A3445-01; Protocol #13001)
Imaging and image analysis
One or two days after electroporation, slices expressing Camui were cut out of the 6-well insert
membranes used for their support and were transferred to the glass bottom of a custom-made
recording/imaging chamber placed on a custom-made motorized stage. Slices were completely
submerged in a circulating ACSF (flow rate 2.5–3 ml/min) of the following composition
(in mM): 124 NaCl, 2.5 KCl, 4 CaCl2, 4 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 20 Dextrose,
0.001 TTX, balanced with 95% O2 and 5% CO2, pH 7.4 at room temperature (22C°–24C°).
Slices were equilibrated in these conditions for at least 30 min before imaging. Imaging was
performed using a custom-made two-photon microscope system, as described in [32,44]. The
system was equipped with a Coherent XR two-photon laser, two fast PMTs (H7422-40),
SPC150 FLIM board (Becker- Hickl, DE), Pockels cell (Conoptics, CT), and 60× 1.0 NAWI
(Olympus, JA) objective. Time-lapse FLIM imaging and analysis were performed using custom
software, as described in [32,44]. GFP and mCherry were excited by mode-locked IR at 920 nm.
Green and red emissions were separated by DCXR 565 nm dichroic and HQ 510/70 nm
and ET630/60—P blocking filters (both from Chroma technology). Normally, a Z stack of
5–7 focal steps (1 μm) was acquired to image a dendritic segment. Each focal plane image
(128 × 128 pixels at 0.1 μm pixel size) was averaged 30–60 times. Weak laser intensity (~1.0 mW
under the objective) was used to minimize bleaching and photodamage. Time-lapse imaging
was done every 2–8 min. Green PMT signal was recorded in single-photon counting mode
(SPC), and two types of images were constructed: one—presenting averaged number of pho-
tons per pixel (SPC image) and the second—presenting averaged single photon lifetime per
pixel (FLIM). Red fluorescence was recorded in standard integral mode. Analysis was per-
formed from the maximal projection images of each stack. Background was subtracted from
SPC image to determine cell edges, and then ROI were drawn around individual spines and
along the dendrite or at a proximal part of cell body that did not include the nucleus. Special
care was taken to avoid bright spots on the dendritic shaft of the SPC image, which could repre-
sent spines or occasional protein aggregates. Further analysis was done using integral SPC of
spine ROIs and average SPC of dendritic or somatic ROIs. Only ROI pixels positioned within
the cell border were taken into account in these calculations. Average fluorescence lifetime in
spine, dendritic, and somatic ROIs were calculated using FLIM projection images. Morphologi-
cal changes were analyzed qualitatively by visual criteria.
Because fluorescence intensity (SPC) of Camui donor fluorophore (GFP) slightly quenches
due to FRET, the following correction was used for each ROI: Corrected Intensity = Measured
Intensity  (tau_GFP/tau_m), where tau_GFP = 2.6 ns and tau_m = measured average
Camui tau.
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Excitotoxic insults
Previous data showed that treatment of hippocampal neurons with 10μM of NMDA in normal
Mg2+ for 24 hours or with larger concentrations (300 μM) for 5 min produced delayed cell
death in about 50% −80% of neurons [2,45,46]. Because cells depolarization during ischemia
releases Mg2+ block from NMDA receptors, we applied NMDA (25 μM for 5–8 min, as men-
tioned in the text) in ACSF containing 0.3 mM of Mg2+. In a few initial experiments on den-
dritic spines, lower concentrations of NMDA (10 and 15 μM) or lower Mg2+ (0 mM) in the
ACSF were used, but because the effects at different conditions were similar, all results were
pooled together. For summary figures and statistical analysis, only experiments with 0.3 mM
Mg2+ in ACSF were included. Washout was performed with standard ACSF supplemented
with NMDA receptor antagonist D, L APV (100 μM). The first 30 min of the washout was per-
formed using ACSF flow without recirculation to ensure complete removal of drugs from the
slice imaging chamber. ACSF flow was then recirculated for an additional 30–40 min. TTX
(1μM) was routinely used during the whole lengths of experiments to prevent cell spiking.
Drugs
Stock solutions of NMDA (Sigma, 20 mM), D, L-APV (Sigma, 20 mM) and TTX (Abcom Bio-
chemicals, 2 mM) were prepared in deionized water, and their aliquots were kept frozen
until use.
Statistical analysis
All data were presented as mean ± SEM. Student’s t-test (Excel, 2010) or “One-Way Analysis
of Covariance" (http://vassarstats.net/vsancova.html) ANCOVA (Excel) tests were used to cal-
culate statistical significance between sets of data. Noise level of fluorescence lifetime record-
ings was calculated as 95% confidence interval from data obtained in ~180 minute time-lapse
imaging of cell somas (baseline control).
Results
Camui activation state and expression pattern at basal conditions
To study how excitotoxic insults affect CaMKII activity in living cells, we transfected pyramidal
CA1 neurons in hippocampal slice cultures with cDNA of CaMKII activity probe, Camui. Camui
green fluorescence was recorded in both single photon counting (SPC) and lifetime modes; and
the respective two types of images were constructed online. SPC images represent spatial distri-
bution of Camui fluorescence intensity (average number of single photons per pixel) in cell. This
measure is proportional to the protein amount of Camui within a subcellular region. FLIM im-
ages depict average fluorescence lifetime of green photons of Camui (time between the fluoro-
phore excitation and emission) expressed in nanoseconds per pixel. The fluorescence lifetime
reflects different conformational states of CaMKII: longer lifetime corresponds to more open
(“active”) conformation (see “Introduction” for additional explanation).
Camui spatial distribution in cell bodies and dendrites was, in general, homogeneous except
that almost no protein was visible in the cell nuclei (Fig. 1A, SPC), as expected [32,43]. Com-
parison of the fluorescent lifetime of Camui in neighboring cells revealed a large variability
(0.088 ± 0.01 ns, 9 slices, 26 cells, Fig. 1A2, C). Previous studies reported that the CaMKII
amount in spines correlated with spine size and synaptic strength [47]. Interestingly, in the cur-
rent study, we find that although Camui amount was also quite variable between spines
[41,47], the activation state of Camui in different spines was similar (R2 = 0.06; Fig. 1B, S1 Fig.
panel B and S1 Text). Furthermore, the basal level of CaMKII activation in spines and in
CaMKII in Excitotoxicity
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adjacent dendritic shaft of the same dendritic branch was also similar (1.99 ± 0.01 ns in spines
and 1.97 ± 0.02 ns in dendritic shafts, 27 branches, p> 0.05). Likewise, we observed no differ-
ence between basal Camui activation in cell somas and dendrites (1.99 ± 0.03 ns in somas,
n = 26 and 1.97 ± 0.02 ns in dendritic shafts, n = 27 respectively, p> 0.05).
Thus, although basal Camui activation significantly varied even between neighboring cells,
it was similar in all characterized cellular compartments (spines, dendritic shafts, and cell
somas) of individual cells.
In neuronal dendrites, NMDA challenge produces either persistent or
transient Camui activation with concomitant redistribution to spines
After 30 min of baseline imaging, slices were subjected to bath-applied NMDA (25 μM) for
5 min while time-lapse imaging continued every 2–8 min for at least 40–60 min. The Mg2+
Fig 1. Basal Camui activity is uniform across spines, dendritic shafts, and somas of the same cell, but differs between cells. (A) Representative low-
magnification (A1-3) and high-magnification (B1-3) images of Camui fluorescence lifetime (FLIM) and single-photon counting (SPC) obtained in different
experiments. Brighter colors correspond to lower level of Camui activation (shorter lifetime) in FLIM images and to higher Camui green fluorescence (more
photons) in SPC images. Camui activity could be similar (A1) or very different (A2-3) in different cells. The insert (A3, SPC) shows a single focal plane image
through the middle of cell bodies, demonstrating no Camui expression in the cell nuclei. Note that (B1-3) images are not zoomed in regions of images shown
in (A1-3). Image sizes: (A1-A2): 60 μm, (A3): 20 μm, (B1-3): 12 μm; Pseudo-color scales, ns (FLIM) and a.u. (SPC). (C) Graph demonstrates that different
cells in the same slice may have very different fluorescence lifetime in somatic region, suggesting different level of Camui activation (n = 26). Each data point
represents a value of fluorescence lifetime for each cell in the same image (slice) normalized to the minimum fluorescence lifetime value in that image.
doi:10.1371/journal.pone.0120881.g001
CaMKII in Excitotoxicity
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concentration of the ACSF during the NMDA application was reduced to 0.3 mM to partially
release Mg2+ block of NMDA receptors, which, during an actual ischemic episode, occurs as a
result of cell depolarization. The washout of the NMDA was performed using ACSF with stan-
dard Mg2+ and 100 μM of APV (an NMDA receptor antagonist). APV was included to facili-
tate termination of NMDA effect because the cellular glutamate uptake mechanism cannot
remove this glutamate analog.
In this series of experiments, one dendritic segment per slice was studied in an experiment.
Transient NMDA application produced two major types of Camui responses. In group I (7 of
16 experiments), Camui activity increased during the NMDA application and maintained this
activated state for the entire recording (see a representative example in Fig. 2A, B). In the sec-
ond major group (group II, 5/16) NMDA stimulation produced only transient Camui activa-
tion, with activity returning to baseline level or below baseline within 20–30 min (an example
in Fig. 2C, D). In both groups, the amount of Camui in spines (estimated by GFP fluorescence
intensity) increased during the NMDA treatment, consistent with previous reports [48].
Camui amount in group I dendrites decreased concomitantly with its increase in spines, sug-
gesting a translocation of Camui from dendrite to spines similar to what was observed for en-
dogenous CaMKII in ischemic conditions [49]. In group II, Camui amount in dendrites did
not significantly change, suggesting that the increase in Camui fluorescence in spines was due
to an increase in spine size or local translation rather than its translocation from dendritic
shafts. In general, the increase in the spine fluorescence was concomitant with the change of
Camui activity: persistent in group I but transient in group II (Fig. 2A, C, bottom panels). In
group II, however, the increase of Camui fluorescence in spines often lasted longer than Camui
activation (Fig. 2C and S2 Fig.).
In addition to these two major groups, two other types of Camui reactivity following
NMDA treatment were observed (S3 Fig., S1 Table). Fluorescence lifetime measurements were
very noisy in group III (3/16) and showed no change in group IV (1/16). Camui fluorescence
intensity decreased in both spines and dendrites in group III but in group IV it only decreased
in spines while dendritic fluorescence remained stable. Also significant cell swelling/shrinkage
was evident in both of these groups (S3 Fig., panel C), whereas cells in groups I and II displayed
little or no dendritic swelling or shrinkage (Fig. 2, S2 Fig. and S4 Fig.).
The summary data for all 16 experiments (Groups I–IV) are shown in Fig. 3A. Despite dif-
ferent Camui reactivity patterns in different groups, overall NMDA treatment produced a
small but significant persistent elevation in Camui fluorescence lifetime (0.034 ± 0.012 ns in
spines and 0.025 ± 0.016 ns dendrites, p< 0.001 for both) in these combined data. The com-
bined data also showed that the Camui fluorescence intensity persistently increased in spines
(~ 20%; p< 0.001) and decreased in the dendritic shafts (~ 20%; p< 0.001), resulting in a dra-
matic increase (60%) in the spine/dendrite fluorescence ratio. Averaged data for groups I and
II are shown in Fig. 3B,C and look very similar to the previously described representative exam-
ples from these groups (Fig. 2). Notably, for all four groups, there was no statistical difference
between general dynamics of fluorescent lifetime changes in spines and in dendritic shafts (S3
Text).
Therefore, NMDA insults produced either persistent or transient Camui activation in den-
drites and spines with, in general, concomitant redistribution of Camui to spines. In dendrites
with transient Camui activation, however, the redistribution of Camui amount on average
lasted longer than its activation, suggesting that the maintenance of Camui activation and its
protein redistribution may have different regulation or phases.
CaMKII in Excitotoxicity
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Fig 2. Examples of Camui reactivity in dendrites in response to 5 min NMDA treatment. (A) Top panel: NMDA application (grey bar) resulted in a
persistent activation of Camui (increased fluorescent lifetime) in both spines (open circles) and dendritic shafts (filled circles), which remained above the
baseline for at least 55 min after the washout; bottom panel: Corresponding fluorescence intensity persistently increased in spines (open) and decreased in
dendritic shafts (filled), resulting in a dramatic increase in the spine/dendrite fluorescence ratio (triangles). (B) Images of FLIM (top) and fluorescence intensity
(SPC, bottom) before, during NMDA application, and 40 min of washout for the experiment shown in (A). (C) Top panel: NMDA application (grey bar) resulted
in a transient increase in fluorescence lifetime of Camui in both spines (open circles) and dendritic shafts (filled circles), which decayed to below baseline
level by 30 min of washout; bottom panel: Corresponding fluorescence intensity in spines (open circles) transiently increased while remaining stable in
dendritic shafts (filled circles), resulting in a transient increase in the spine/dendrite fluorescence ratio (triangles). (D) FLIM and SPC images before, during
NMDA application, and at 22, 27, and 43 min of washout for the experiment shown in (C). Note that many spines became smaller or completely eliminated at
the end of the experiment (43 min of washout). Pseudo-color scales, ns (FLIM) and a.u. (SPC).
doi:10.1371/journal.pone.0120881.g002
CaMKII in Excitotoxicity
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Camui activation by NMDA challenge is uniform across multiple
subcellular compartments: soma, dendrites, and spines
We next investigated Camui reactivity to NMDA treatment in neuronal soma. To address
whether Camui activation in neuronal somas was similar or different to the activation seen in
dendrites, simultaneous Camui measurements were collected from soma and dendrites of the
same cell. Similar to what was observed in dendritic regions, Camui activation in the cell body
after 5 min NMDA application was either persistent for more than 60 min (4/7 experiments)
or transient (3/7 cells), returning to the baseline at ~25 min after initial activation by NMDA
Fig 3. Summary of Camui reactivity in dendrites in response to 5 min NMDA treatment. (A) Top panel: Average of all 16 experiments (Groups I–IV);
NMDA application (grey bar) resulted in a persistent increase in fluorescence lifetime of Camui in both spines and dendritic shafts, which remained elevated
for at least 55 min after the washout; Bottom panel: fluorescence intensity of Camui in spines persistently increased (open circles), while the fluorescence in
dendritic shaft concomitantly decreased below the baseline (filled circles), resulting in a dramatic increase in the spine/dendrite fluorescence ratio (triangles).
(B) Top panel: summary plots of group I (7/16) experiments showing that application of NMDA (grey bar) resulted in a persistent increase in fluorescence
lifetime of Camui in both spines and dendritic shafts (p< 0.05 for both) and remained elevated for at least 55 min (p< 0.05 for both) after the washout;
bottom panel: fluorescence intensity of Camui in spines persistently increased (p< 0.05, open circles), while the fluorescence in dendritic shafts
concomitantly decreased below the baseline, (p< 0.05, filled circled), resulting in a dramatic increase in the spine/dendrite fluorescence ratio (triangles). (C)
Top panel: summary plot of 5/16 experiments (group II) showing that NMDA application (grey bar) produced only a transient increase in fluorescence lifetime
of Camui in both spines and dendritic shafts (p< 0.05 for both) immediately after the NMDA application, but decreased in spines and in dendrites at 30 min of
the washout; bottom panel: fluorescence intensity of Camui in spines remained elevated (open circles) for at least 30 min of NMDA washout, but then
gradually retuned to the baseline by 45 min. The Camui fluorescence in dendrites (filled circles) did not change significantly, and the spine/dendrite
fluorescence ratio (triangles) followed the general time course of the change in the fluorescence in spines.
doi:10.1371/journal.pone.0120881.g003
CaMKII in Excitotoxicity
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(Fig. 4A). Peaks of Camui activation were similar in both of these groups (lifetime change ~0.2
ns, p> 0.05). However, in cells with the transient activation, Camui slowly deactivated and
then further dropped below the baseline level during the washout period (40–70 min), consis-
tent with the presence of the basal level of Camui activity. Comparative Camui activation data
for somas and dendrites are shown in S5 Fig. panels A, B. Again the results were grouped in re-
spect to the type of the reactivity: persistent (A) and transient (B) activation. For both groups,
the dynamics of Camui activation after the NMDA treatment were not different between so-
matic and dendritic regions. Therefore, the results indicate that Camui activation dynamic
after transient NMDA treatment was uniform in all tested cellular compartments: dendritic
spines, dendritic shafts, and cell somas.
Complex spatial redistribution of Camui in neuronal somas after NMDA
treatment
Camui spatial redistribution in neuronal somas after NMDA treatment had multiple phases.
During NMDA application, Camui initially changed from almost homogenous distribution to
a string-like pattern, with “strings” seeming to be oriented from the nucleus toward the apical
dendrite (Fig. 4C, “NMDA”, and S5 Fig., panel D, “NMDA”). Five to ten minutes (7.1 ± 0.4 min
on average, n = 7) after the start of the NMDA application, the string-like pattern slowly
transformed to numerous small clusters distributed through the whole cell body, as evident in
single images taken at different focal planes (S5 Fig., panel C). In several cases, it could be seen
that the clusters were also oriented in string-like patterns resembling the pattern formed during
the NMDA treatment before clustering (S5 Fig., panel D). These observations suggest that the
clusters might be attached to the same intracellular organelles that targeted the Camui during
the NMDA treatment. These initial dynamics of Camui redistribution were similar in both
groups (with transient and persistent activation, Fig. 4C) except that, in the persistent group,
clusters were formed in all cells (100%) shortly after NMDA application and persisted until the
end of experiments in ~75% of these cells (Fig. 4B, C, “persistent”), while in the “transient”
group, clusters were formed only in 68% of cells and were largely dissolved back into homoge-
nous fluorescence by the end of these experiments (Fig. 4B, C, “transient”). These data seem
to suggest that persistence of clusters in cell bodies correlate with the persistence of Camui
activation.
Somatic Camui clusters could persist longer than Camui activation
The correlation between persistence of Camui clustering and persistence of Camui activation
(Fig. 4A–C) raised a possibility that the apparent Camui activation state could be a result of
Camui self-association when regulatory domains of one holoenzyme bind to and inhibit cata-
lytic domains of neighboring holoenzymes [26,28,29,37,50]. Detailed analysis, however, reveals
that clusters in these experiments could persist longer than Camui activation. For example,
Fig. 4A shows that at 35 min after NMDA washout, Camui activation completely returned to
the baseline while clusters still persisted (Fig. 4C, “transient”). To further investigate this phe-
nomenon, we performed experiments with longer NMDA treatment (7.5 min [Fig. 4D–F] in-
stead of 5 min [Fig. 4A–C]). The longer NMDA exposure not only raised the percentage of
cells with persistent Camui activation (65% versus 57%) but also prolonged the duration of the
transient activation (~45 min versus ~28 min). Importantly, the longer NMDA application sig-
nificantly increased the percentage of cells with persistent clusters in the group with transient
Camui activation: 71% of cells retained clusters until the end of experiment in comparison to
0% in that group after 5 min NMDA treatment (compare Fig. 4, panels B, E, “transient”).
These results further indicate that, similar to what was observed in dendritic regions, the
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Fig 4. Camui activation and redistribution in neuronal somas after 5 min and 7.5 min NMDA treatment. In neuronal somas, Camui activation (A) in
response to 5 min NMDA treatment was also either persistent (open squares) or transient (filled squares). (B) Camui clustering was persistent in cells with
persistent Camui activation (75% of cells maintained clusters until the end of experiment) but was only transient in cells with transient activation (0%
maintained clusters). (C) Images of Camui fluorescence lifetime (FLIM) and its fluorescence intensity (SPC) for groups with persistent and transient Camui
CaMKII in Excitotoxicity
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persistence of Camui activation and the stability of its spatial redistribution are not strictly cor-
related, suggesting that these two processes are regulated by a distinct mechanisms or have
different phases.
Changes of Camui fluorescence intensity after NMDA treatment were more complex in cell
somas in comparison to that in dendrites (Fig. 4C, F). The somatic fluorescence showed no di-
rect correlation with Camui activation (S8 Fig. and Fig. 4A, D) and could possibly be explained
by complex changes in intracellular pH which is known to affect GFP fluorescence [51]. To
confirm that NMDA treatment in our experimental conditions also produced clustering of en-
dogenous CaMKII, we preformed immuno-staining of non-transfected cells. S9 Fig. shows that
NMDA treatment does cause clustering of endogenous CaMKII.
Camui mutants I205K and K42R did not prevent cluster formation
Previous studies suggested that CaMKII self-association occurs due to binding of regulatory
and catalytic regions of subunits belonging to different holoenzymes [28,29,37]. These studies
demonstrated that CaMKII mutations such as I205K (that affects the interaction between
CaMKII and NMDA receptor [52]) and K42M (that makes the kinase catalytically dead [53])
prevented CaMKII self-aggregation [28,29,30]. Therefore, we tested whether Camui mutants,
I205K or K42R (the latter is another variant of the catalytically dead CaMKII mutant [54,55])
would form clusters in our experimental conditions. S6 Fig. shows that both Camui mutants
produced strong persistent activation after the NMDA treatment and formed persistent clus-
ters that lasted until the end of each experiment (~70 min). These results are consistent with
the suggestion that persistence of Camui activation and persistence of cluster maintenance are
controlled by different mechanisms (more discussion in S4 Text).
Persistent Camui activity is Ca2+- dependent
In searching for mechanisms underlying the persistence of Camui activation by NMDA insult,
we considered the contribution of T286 autophosphorylation [12,22,23,24,56,57] and C280/
M281 oxidation [34,58] to this process: two mechanisms that could lead to persistent CaMKII
activity following Ca2+/CaM dissociation. To explore the role of oxidation and autophosphory-
lation, we generated a double mutant that cannot be oxidized on these residues (C280V/
M281V) [34], as well as a triple mutant (T286A/C280V/M281V) that is deficient for both the
autophosphorylation and the oxidation. Using either of these mutants, we still observed strong
persistent activation (Fig. 5A, p< 0.001), indicating that the persistence of Camui activity was
not due to autonomous activation by these mechanisms. Interestingly, Camui activation was
significantly larger (p< 0.05 for both mutants) than activation of WT Camui, suggesting that
both types of autonomous CaMKII states influenced the magnitude of the CaMKII activation
in our experimental condition. Clustering was not affected by these mutations: persistent clus-
ters were formed in about 90% of cells in both Camui mutants as well as in WT Camui (S5
Text).
activation taken before, during, and at different times (in minutes) after the 5 min NMDA treatment. Note that there was no direct correlation between the
magnitude of the Camui activation and clustering: clustering remained after Camui activation returned to the baseline (Persistent, 35 min). (D) Extended
(7.5 min) NMDA treatment produced sustained somatic Camui clusters, which persisted longer than Camui activation. Summary graph showing persistent
(open squares, 13/20 cells) and transient (filled squares, 7/20 cells) Camui activation. (E) Camui clustering was persistent in both groups of cells (with
either persistent or transient Camui activation). Notably, 71% of cells with transient Camui activation maintained clusters until the end of the experiment in
comparison to 0% (B). (F) Images of Camui fluorescence lifetime (FLIM) and its fluorescence intensity (SPC) for groups with persistent and transient Camui
activation taken before, during, and at different times (in minutes) after the 7.5 min NMDA treatment. Note that somatic Camui clusters persisted to the end of
experiments in both these examples. For better contrast, the upper scale for the last SPC image was changed to 270 (C, 70') and 220 (F, 68'). Pseudo-color
scales, ns (FLIM) and a.u. (SPC).
doi:10.1371/journal.pone.0120881.g004
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An alternative possible explanation for persistent Camui activation is that it occurred due to
a sustained Ca2+-dependent process. About 60 min after the NMDA treatments, we replaced
standard ACSF with ACSF containing 0 mM Ca2+ and 5 mM EGTA to lower extracellular
Ca2+ level. Fig. 5B shows that, in these experiments, a previously induced persistent Camui
activation slowly reverted to the basal level and then below the basal level. In control experi-
ments, in which Ca2+ level was not altered, Camui activity remained persistently activated at
the level significantly above basal level (0.024 ± 0.012 ns, p< 0.003). A separate control showed
that the basal level of Camui activation was stable (-0.008 ± 0.008 ns relative to the period be-
fore NMDA, p> 0.05) for the total duration of the experiment (> 3.5 hours). Interestingly,
this level was slightly higher than the stable lowest level of Camui activation achieved by pro-
longed incubation in 0 mM Ca2+/EGTA ACSF (-0.32 ns ± 0.015). Although this difference did
not reach statistical significance (p = 0.059), there was a strong correlation between basal
Camui activity and the depth of the Camui deactivation below the baseline (R2 = 0.6, p< 0.05).
Together, these latter findings suggest that a population of neurons can have a stable basal level
of CaMKII activity and are consistent with the observation that Camui basal activation state in
neighboring cells can be different (Fig. 1B). Importantly, although Camui activity during the
EGTA treatment decreased below the baseline level, clusters formed after NMDA insult
Fig 5. Persistent Camui activity is Ca2+-dependent. (A) Summary plots of Camui activation in control experiments (open squares, WT Camui, n = 16) and
experiments with Camui mutants (286A/280V/281V, filled squares, n = 18) (280V/281V, n = 12 filled diamond) in response to 7.5 min of the NMDA treatment
(grey bar). The magnitude of the activation of Camui mutants was significantly larger than that of WT Camui (thin horizontal line, p< 0.05 for both mutants).
(B) Application of ACSF containing 0 mMCa2+ and 5 mMEGTA (black horizontal bar) at 60 min after the 7.5 min of NMDA treatment (grey bar) effectively
reversed persistent Camui activation (EGTA, n = 6, circles, p< 0.05), while Camui activity remained persistent in control experiments without lowering Ca2+
(Control, n = 6, squares). Baseline control (n = 3, triangles) was stable for the duration of the experiments (> 3.5 hours). (C) SPC images before, during, and
at different times after the NMDA treatment show that Camui clusters persisted during the whole experiment and were not dissolved at the end of the
experiment after the prolonged exposure to 0 mMCa2+/5 mM EGTA ACSF (198’).
doi:10.1371/journal.pone.0120881.g005
CaMKII in Excitotoxicity
PLOS ONE | DOI:10.1371/journal.pone.0120881 March 20, 2015 13 / 24
remained stable until the end of all these experiments (> 2.5 hours, n = 6, Fig. 5C). This obser-
vation further confirms that the cluster maintenance and the persistent Camui activation are
controlled differently.
NMDA treatment produces persistent mitochondrial damage
Ischemia and excitotoxicity are known to produce delayed neuronal cell injury and death [5].
Mitochondrial lesions occur during this period and are thought to be one of the main causes of
the ischemic cell injury in both the brain and the heart [39,59]. Therefore, we monitored mito-
chondrial morphological integrity by expressing fluorescent mitochondrial marker mito-
dsRed. The marker clearly labeled mitochondria in somas and dendrites of CA1 neurons with-
out almost any background fluorescence (S7 Fig.). We coexpressed Camui and mito-dsRed and
monitored Camui reactivity and mitochondrial integrity simultaneously in neuronal somas be-
fore and after the 7.5 min NMDA insult. Under basal conditions, mitochondrial labeling re-
vealed a dense mesh of thin (< 1 μM in diameter) string-like structures filling the cytoplasmic
region of the neuronal soma, excluding the nucleus (Fig. 6B, S7 Fig.). NMDA application pro-
duced strong Camui activation (Fig. 6A, n = 40) followed by Camui redistribution in a string-
like pattern and subsequently in small clusters, as described earlier. Clusters were formed, on
average, 8 min (8.3 ± 0.3 min, n = 37) after the start of the NMDA application. At this time, no
clear change of mitochondrial morphology was observed (Fig. 6B, 8’). One to five minutes
later, however (on average at 10.3 ± 0.4 min, n = 37, after the start of NMDA, Fig. 6C), clear
signs of change in mitochondrial morphology were evident: string-like structures seemed to be-
come shorter but larger in diameter (Fig. 6B, 13’, S7 Fig.) [60]. This change in mitochondrial
morphology after ischemia has been characterized as swelling [39] although the actual volume
could be smaller [61]. The somatic Camui clustering occurred in 100% (n = 27) of experiments
in the group of the persistent Camui activation and remained until the end of the experiment
in all of these cells (data not shown). The mitochondrial swelling also occurred in all cells of
this group, and it persisted until the end of the experiment in 96% of them. In the group with
transient Camui activation, clustering occurred in 92% (n = 13) and remained in 85% of them
until the end of experiment, while mitochondrial swelling occurred in 77% and remained until
the end only in 46% (n = 13) of cells (Fig. 6D, E). Therefore, our protocol for the NMDA-in-
duced toxicity was effective in producing clear signs of prolonged (> 1 hour) mitochondrial
damage. Importantly, the magnitude of these toxicity signs correlated with the persistence of
Camui activation (Fig. 6E).
Discussion
The goal of this study was to further investigate the role of CaMKII in neuronal damage in-
duced by ischemic/excitotoxic insults. Specifically, our aim was to complement existing bio-
chemical data with results obtained in living neurons. To achieve this, we employed a high
spatial/temporal resolution method of monitoring CaMKII activation and spatial redistribu-
tion in different neuronal compartments such as spines, dendritic shafts, and cell somas using
CaMKII activity FRET reporter Camui [32,33].
Activation state of CaMKII in silent neurons at basal conditions
We observed that, under basal conditions in our slice cultures, the Camui activation state was
similar in multiple compartments (spine, dendritic shafts, and somas) of individual cells, yet
this activation differed considerably between different cells in the same slice. The latter obser-
vation was interesting because neuronal firing in our experiments was eliminated by TTX. We
hypothesize that the observation could be explained by different cells possessing different
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resting states of free Ca2+/CaM availability, which is not directly coupled to neuronal spiking.
Consistent with this idea, the basal Camui activity could be tentatively suppressed below base-
line levels by lowering extracellular Ca2+ concentration with extracellular EGTA; with the de-
gree of this suppression greatest in cells with higher basal Camui activity. Previous biochemical
data demonstrated that the resting level of intracellular Ca2+ is sufficient to maintain autono-
mous activation through persistent Ca2+-dependent autophosphorylation at conditions similar
to ours (slice cultures, TTX) [62]. Therefore, one explanation of our results could be that some
amount of autonomous activity was present at basal conditions in some cells in our experi-
ments as well. However, comparison of fluorescent lifetimes of WT Camui and Camui mutants
deficient of autonomous activation showed no significant difference (data not shown), suggest-
ing that the contribution of the autonomously active kinase at basal conditions was minimal or
not present at all and that the differences in the basal level of Camui activation may reflect cel-
lular differences in resting cytoplasmic Ca2+ /CaM levels (see below).
Fig 6. NMDA treatment resulted in a persistent mitochondrial swelling following Camui activation and clustering. (A) Summary graph showing
persistent and transient increase in the fluorescence lifetime of Camui after NMDA treatment (grey bar). (B) Representative images of mitochondrial marker
(mito-Red) and Camui intensity (SPC) at different times: before, during, and after NMDA application (in minutes). (C) Bar diagram indicating average times for
Camui clustering (Camui clust.) and mitochondrial swelling (m. swelling). (D) Bar diagram showing the percentage of cells with CaMKII clustering after the
NMDA treatment and at the end of experiments for cells with persistent and transient Camui activation. (E) Bar diagram indicating the percentage of cells with
mitochondrial swelling shortly after the NMDA treatment and at the end of experiments for cells with persistent and transient Camui activation.
doi:10.1371/journal.pone.0120881.g006
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Persistent and transient are two major patterns of Camui activation in
spines in response to NMDA treatment
We observed two major types of Camui responses to transient (~5–8 min) bath application of
NMDA: either persistent or transient activation (group I and group II, respectively). The type
of Camui response in different cellular compartments (spines, dendritic shafts, and somas) was
very similar, indicating that each cell reacted to the NMDA insult as a single unit. It is not clear
what determined the type of Camui reactivity. In most experiments, three cells were imaged si-
multaneously. Using single-cell electroporation, transfected cells were close to each other and
very close to the slice surface (especially somas), minimizing possible differences in local exper-
imental conditions such as ACSF exchange and others. Although the initial peak Camui activa-
tion was not different between these neighboring cells, the deactivation rate could be very
different. The basal levels of Camui lifetime in spines, dendritic shafts, and cell somas revealed
no clear correlation of this parameter with the duration of Camui activation (data not shown).
Therefore, some other individual cell characteristics—perhaps different level/activity of endog-
enous proteins involved in Ca2+/CaM homeostasis—might play a role in determining the type
of Camui reactivity in a particular cell. When the duration of the NMDA application was in-
creased from 5 to 7.5 min, the rate of Camui deactivation significantly slowed down while the
fraction of cells with persistent activation increased. Therefore, the duration of a focal ische-
mia-induced excitotoxic insult in vivomight play a role in determining the overall duration of
CaMKII activation in affected neurons.
CaMKII redistribution in dendrites and spines
Camui activation by NMDA treatment often coincided with an increase of Camui amount in
spines and its decrease in dendrites. This observation is consistent with previous cell biological
studies showing that strong cell excitation or ischemia resulted in translocation of CaMKII to
spines or synaptic puncta [28,41,48]. Ultrastructural EM studies of neurons following excito-
toxic calcium signaling revealed that CaMKII accumulates in the postsynaptic density (PSD) of
excitatory synapses [41,49]. Some of the kinase that translocates to spines may exist in multi-
meric structures, similar to self-associated aggregates that form within the cytoplasm following
strong excitation or ischemia [26,28,29,37,63]. Although the duration of the dendritic/spine re-
distribution of Camui amount observed in our experiments, in general, correlated with the du-
ration of Camui activation, often the duration of Camui redistribution into spines lasted longer
than Camui activation (Figs. 2, 3 and S2 Fig.). This suggests that, unlike the initiation of the
CaMKII redistribution to spines, which requires CaMKII activation, the maintenance of the
translocated kinase may not need CaMKII activation, indicating different regulation or phases
of these two processes (see additional discussion below).
CaMKII activation and clustering in cell somas
In cell bodies, Camui distribution after NMDA treatment underwent a complex spatial trans-
formation. The initial transformation of near homogeneous Camui distribution into a string-
like pattern resembles activity-dependent translocation of CaMKII from cytosol to microtu-
bules [55]. Similarly to the microtubule translocation, the string-like pattern that we observed
was very short-lasting (1–3 min), being quickly replaced by numerous dense clusters. These
clusters closely resembled large (~100–300 nm) globular self-associated CaMKII aggregates/
clusters described by others in primary cells at ischemic/excitotoxic conditions [26,28,29,63].
In in vitro experiments, CaMKII cluster formation required Ca2+/CaM-dependent transition of
CaMKII into open “active” conformation, whereby aggregated CaMKII molecules slowly lost
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their Ca2+/CaM-dependent and-independent activity toward peptide substrates [50]. The for-
mation of these clusters, termed self-association, was proposed to result from the regulatory
and catalytic domains of different CaMKII holoenzymes forming inter-holoenzyme binding
[28,29,37]—a process that locks associated subunits in an open but enzymatically inactive
state. Thus, in a simplified model, most Camui molecules could maintain persistent open con-
formation (“activation”) observed in our study due to this type of molecular association. Fur-
ther analysis, however, suggested against this simple model: Camui could change its
conformation state from open “active” to closed “inactive” conformation without dramatic
change in its clustering level. One possibility is that the mechanism of cluster maintenance in
our experimental conditions was different from that described in the previous publications.
Consistent with this possibility, two Camui variants, with mutations that prevented CaMKII
clustering in previous studies (I205K and K42R) [28,29,30], did not alter clustering in our ex-
periments (see S4 Text for additional discussion). Another interpretation is that, in our experi-
ments, Camui formed loosely packed clusters, with only a few subunits in each dodecameric
holoenzyme participating in the self-association type aggregating reaction. In this case, all
other subunits would retain their ability to change conformation from open (active) to closed
(inactive) state without affecting cluster structure. Consistently, these loosely packed clusters of
partially active CaMKII were observed in vitro during early phases of the kinase aggregation
[37,50]. Regardless of the cluster maintenance mechanism, the clustered kinase, while retaining
ability for activation, is likely to have restricted enzymatic function due to a loss of its proper
targeting and substrate availability, as previously postulated [26,37]. Therefore, our data sug-
gest that, in a large population of cells in our experiments, excitotoxic insult produced a persis-
tent Ca2+-dependent activation of CaMKII, with restricted function due to strong kinase
clustering.
Contribution of Ca2+-dependent and autonomous states in persistent
CaMKII activation
Our analysis suggest that the persistent Camui activation after the NMDA treatment was most-
ly Ca2+-dependent due to a prolonged elevation of cytosolic calcium, with a little impact of au-
tonomous state. This conclusion is based on two observations: first, the persistent Camui
reactivity was not blocked by CaMKII mutations, which prevent generation of autonomous
states through either autophosphorylation of T286 or oxidation of C280/M281; second, the
persistent Camui activation was reversed when Ca2+ was replaced by EGTA in the bath ACSF.
These observations, however, do not exclude that a fraction of CaMKII pool was either autop-
hosphorylated at T286 or oxidized at C280/M281 because these modifications seem to contrib-
ute very little if any to the total Ca2+/CaM-stimulated activity of the kinase [9,34,58,64,65].
Consistently, we found that the magnitude of the persistent Camui activation was only margin-
ally influenced by mutations preventing autonomous (“open”) states of CaMKII trough T286
autophosphorylation or C280/M281 oxidation. Biochemical works in vitro reported that T286
phosphorylation could either increase or decrease the total Ca2+-stimulated CaMKII activity,
indicating that results could depend significantly on experimental conditions ([64,65] and oth-
ers). Our data suggest that in the environment of the living cell, the autonomous activation
slightly decreases the total Ca2+-stimulated WT CaMKII activation because the autonomous-
deficient CaMKII mutants used in our study produced slightly larger persistent activation. In-
dependent of the interpretation, the results suggest that some CaMKII autonomous state did
occur after NMDA challenge. Importantly, our study also revealed that Camui mutants that
are deficient exclusively in oxidation-dependent autonomous state (CM28/281VV) also
showed significantly larger persistent activation than that of WT Camui. This finding strongly
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indicates that this specific type of oxidation-dependent CaMKII regulation can be activated in
neurons at excitotoxic conditions. To our knowledge, our results are the first demonstration of
the existence of this type of oxidation-dependent CaMKII regulation in the brain confirmed by
the mutational analysis.
Is CaMKII autonomous state involved in excitotoxic cell damage?
In ischemic heart, CaMKII autonomous activation has been suggested to play a critical role in
promoting cell damage, though the mechanisms are not completely understood [66,67,68]. Re-
cent studies also implicated the autonomous state of CaMKII in neuronal damage produced by
ischemia/excitotoxicity [2,4], but that mechanisms are also not clear. Our finding that autono-
mous state of CaMKII was generated in neurons by an excitotoxic insult in general is consistent
with this implication. It seems puzzling, however, how the T286 autophosphorylated kinase
state, which contributes very little if at all to the total Ca2+-stimulated enzymatic activity
[9,64,65], can cause a significant effect on cell toxicity? Two possibilities look plausible. One is
that cell Ca2+ was not persistently elevated during the post-stroke period in the experimental
conditions of that study. Another intriguing possibility is that CaMKII participated in toxic
processes not through its enzymatic autonomous activity but through targeting which requires
its T286 autophosphorylation even in the presence of elevated Ca2+. CaMKII binding to NR2B
receptor is one form of this type of targeting [52] and it was shown to play a role in ischemic
toxicity [24,69]. Notably, CN21 peptide inhibitor of CaMKII which inhibits post-stroke cell
toxicity [2,3] not only interferes with formation of CaMKII/NMDAR complex in vitro [70] but
also reduces the existing complex in living brain slices [71]. Our finding that most of Camui ac-
tivation after the excitotoxic insult was Ca2+-dependent with a little impact of autonomous
CaMKII state is in agreement with this last interpretation. It would be interesting to implement
FRET based imaging of CaMKII targeting after excitotoxic insults to test this hypothesis.
Persistent Ca2+ elevation, CaMKII activation and mitochondrial damage
Although cytoplasmic Ca2+ overload in general is the integral feature of ischemia/reperfusion
processes, it is the long-lasting Ca2+ elevation that has been linked to delayed cell death after is-
chemia [39,59]. A prolonged (a few minutes to many hours) Ca2+ rise in neurons after short in-
sults was reported both in animals in vivo and in live neurons in vitro [72,73,74,75].
Mitochondrial Ca2+ overload and following mitochondrial damage has been considered as one
of the most likely causes of this sustained Ca2+ increase (delayed Ca2+ deregulation) and cell in-
jury [39,59]. If the initial Ca2+ overload does not exceed critical level, the mitochondrial dam-
age may recover, leading to restoration of intracellular Ca2+ and to cell survival [39,59]. Our
data seems to be in line with this hypothesis. We found that mitochondrial swelling occurred
with a delay of several minutes after NMDA insult and the persistence of this mitochondrial
damage correlates with the persistence of Camui activation which is mostly Ca2+-dependent.
Therefore, it is plausible that the persistence of CaMKII activation after excitotoxic insult is
controlled by Ca2+ deregulation, which at least in part depends on mitochondrial damage. In
addition, over-activated CaMKII itself has a potential to promote the toxic deregulation of
Ca2+ homeostasis [66,67,68,76].
Conclusions
Our results support the idea that an excitotoxic insult produces a persistent Ca2+-dependent
activation of CaMKII, with a limited impact of the kinase autonomous states dependent on
T286 phosphorylation or C280/M281 oxidation. The overall functional enzymatic effect of the
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kinase, however, is likely to be restricted due to its strong clustering. Further studies are needed
to elucidate a mechanism of the involvement of CaMKII in neuronal excitotoxicity.
Supporting Information
S1 Fig. Negligible level of correlation between Camui activity (fluorescence lifetime) and its
content (fluorescence intensity) in neuronal cell bodies or dendritic spines. Each data point
represents the number of photons (fluorescence intensity) and the average fluorescence lifetime
for each cell soma (A) or spine (B). Data were normalized to the average fluorescence intensity
and fluorescence lifetime for all cells or spines in each image or branch, respectively.
(TIF)
S2 Fig. Two examples showing transient Camui activation but persistent increase in its
spine content after NMDA treatment. (A) Plots of Camui fluorescence lifetime (top panels)
showing that application of NMDA (grey bar) produced only a transient increase of the life-
time, but a persistent increase in Camui fluorescence in spines (bottom panels). (B) FLIM and
SPC images before, during NMDA application, and 34 min of washout for the experiment
shown in (A). Scale bar, 1 μm.
(TIF)
S3 Fig. Additional types of Camui reactivity (groups III and IV) have different characteris-
tics. Groups are characterized by noisy or no lifetime response (A), dramatic decrease of
Camui fluorescence in dendrite (B) and concomitant dendritic swelling (C). See S1 Table.
(TIF)
S4 Fig. Morphological transformations produced by NMDA treatment: spine growth, col-
lapse, and reappearance. (A-C) SPC images taken during different times in three experiments
showing slight swelling/shrinkage (A, B, asterisk), an increase in spine fluorescence intensity
(A, B, arrows), and appearance of new spines (B, C, arrows) induced by NMDA application;
these and other spines disappeared at later times after the NMDA washout. (D) Images show
appearance of filopodia (arrow) at 32 min after the NMDA treatment, but most spines were
collapsed during the later time of the washout (80 min). (E) Many spines collapsed 15 min
after the first NMDA treatment, but some reappeared (arrows) after the second treatment.
(TIF)
S5 Fig. NMDA treatment resulted in the formation of small dense clusters of Camui
through the whole volume of cell body. Camui reactivity in cell bodies (open squares) and
dendrites (open circles) of the same cell was similar: (A)—persistent, (B)—transient. Note that,
in these experiments, dendritic regions were not imaged during the NMDA treatment, and
therefore the comparison can be made only for the period after the treatment when imaging of
both regions was done alternatively. (C) Two columns show individual consecutive Z-axis
frames from two SPC image stacks taken during imaging of two different cell bodies. Numbers
on the left indicate frame numbers starting from cell surface and proceeding deeper inside the
cell with steps of 1 μm; it is evident that new clusters appear and disappear every 1–2 Z steps.
Imaging the same clusters in two consecutive Z steps is expected because the Point Spread
Function in Z axis at this wavelength is ~2.6 μm. (D) SPC projection images during NMDA
treatment (left) before cluster formation and 7 min after NMDA treatment when clusters were
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S6 Fig. Camui mutants I205K and K42R did not prevent cluster formation. (A) Summary
plot of fluorescent lifetime change showing that both Camui mutants (I205K, triangles and
K42R, squares) produced persistent activation after 7.5 min NMDA treatments. (B) Represen-
tative images of Camui fluorescence (SPC) for each mutant, demonstrating that clusters
formed shortly after the NMDA treatment (NMDA) persisted until the end of experiments
~70 min (70’). (C) Summary plot showing that fraction of cells that formed clusters shortly
after NDMA treatment (NMDA) and the fraction that retained these clusters until the end of
experiments (END) were not significantly different between Camui mutants (I205K and
K42R) and control experiments (WT).
(TIF)
S7 Fig. A representative example of mito-DsRed expression in a CA1 neuron. (A) A low-
magnification image of a CA1 neuron showing strong mito-DsRed expression in cell soma and
both apical and basal dendrites. (B–D) Higher-magnification images showing mitochondrial
network in cell body (B), a segment of proximal dendrite (C), and a more distal segment of api-
cal dendrite (D). (E), (F) Somatic mitochondrial network in control conditions. (E) Two im-
ages at times 5 min and 0 min before NMDA and after NMDA treatment. (F) Two images at
10 and 50 min of washout; note clear mitochondrial swelling produced by the NMDA treat-
ment.
(TIF)
S8 Fig. Change in Camui content in cell bodies after 5 (A) and 7.5 (B) min of NMDA treat-
ment. The data are complementary to Fig. 4. During NMDA application, there was always a
short period of increase in Camui content in cell bodies. At ~5–10 min after the NMDA appli-
cation, the Camui intensity in cell bodies reverted to the baseline level. The Camui fluorescence
intensity in the “persistent” group (open symbols) remained near the baseline during the ~ 20–
70 minute period, while in the “transient group” (filled symbols), Camui fluorescence increased
again after 20 min and remained elevated until the end of the experiment.
(TIF)
S9 Fig. Immunostaining of endogenous CaMKII in untransfected cells shows CaMKII
clustering after the NMDA insult. Experiment: Slices with cells coexpressing Camui and
mito-dsRed were treated with NMDA (25μM) and then fixed and processed for CaMKIIα
immunostaining. (A) Camui lifetime change produced by NMDA treatment (average of 4 cells,
arrow indicates the time of slice fixation). (B) Images of one of cells from the experiment
shown in (A) showing mito-dsRed fluorescence before (control) and after NMDA treatment
(NMDA): note mitochondrial swelling produced by NMDA. (C) Images of one of cells from
the experiment shown in (A) showing pattern of Camui distribution (GFP fluorescence) before
(control) and after NMDA treatment (NMDA): note Camui clustering. (D) Images of CaM-
KIIα immunostaning (Alexa 595 tagged secondary antibody) of cells in experiment shown in
(A); insert in the right, top corner shows higher magnification of the region indicated in the
left bottom side of the image; note the endogenous CaMKII clustering after NMDA treatment.
(TIF)
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